InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Black Jeffrey G., Chief Financial Officer. Director active across 3 companies, notably EXAGEN INC.. Aggregated, 8 disclosures have been logged. Total volume traded: €800k. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
US$4,8481,584 shares@ US$3.06090.0055% mcap2.7% of flow
Common Stock
SEC:0001449439-26-000003·
€4,8481,584 shares@ €3.06090.0055% mcap1.4% of flow
Common Stock
SEC:0001449439-26-000003:0·
US$172,19120,466 shares@ US$8.41350.20% mcap97.3% of flow
Common Stock
SEC:0001628280-25-041688·
€172,19120,466 shares@ €8.41350.20% mcap48.6% of flow
Common Stock
SEC:0001628280-25-041688:0·
088,900 shares0
Common Stock
SEC:0001251769-22-000055:0·
€73,45415,000 shares@ €4.896916.5% of flow
Common Stock
SEC:0001251769-22-000020:0·
Ideal exit: 22 Nov 2022 (T+270)
€186,29925,000 shares@ €7.4519100.0% of flow
Common Stock
SEC:0001251769-21-000103·
Ideal exit: 8 May 2022 (T+270)
€186,29925,000 shares@ €7.451941.8% of flow
Common Stock
SEC:0001251769-21-000103:0·
Ideal exit: 8 May 2022 (T+270)
8 of 8 declarations
About Black Jeffrey G.
Jeffrey G. Black is the Chief Financial Officer of Exagen Inc. and Apollo Endosurgery, Inc. He is responsible for the financial management of these companies, including budget planning and financial performance analysis. His role is essential in ensuring the profitability and growth of these organizations. Jeffrey works closely with other executives to align financial and strategic objectives.
